Laboratory evaluation demonstrated hypocalcemia (8.5 mg/dL), hyperphosphatemia (8.4 mg/dL), and a markedly elevated parathyroid hormone (PTH) level of 1695.8 pg/mL. This evidence concerns the gene PTH and hyperphosphatemia.